Submitted by Anonymous (not verified) on 14 August 2023 - 11:24
Human medicines European public assessment report (EPAR): Tolvaptan Accord, tolvaptan, Inappropriate ADH Syndrome, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Tolvaptan Accord, tolvaptan, Inappropriate ADH Syndrome, Status: Authorised